ABIO - ARCA biopharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 59.96M
Enterprise Value 3-100.47k
Trailing P/E N/A
Forward P/E 1-0.44
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.03
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.01

Trading Information

Stock Price History

Beta (3Y Monthly) 2.48
52-Week Change 3-31.61%
S&P500 52-Week Change 35.84%
52 Week High 323.04
52 Week Low 34.68
50-Day Moving Average 36.89
200-Day Moving Average 37.42

Share Statistics

Avg Vol (3 month) 3792.06k
Avg Vol (10 day) 369.55k
Shares Outstanding 5773.56k
Float 1.09M
% Held by Insiders 10.83%
% Held by Institutions 110.85%
Shares Short (Jun 28, 2019) 452.37k
Short Ratio (Jun 28, 2019) 40.15
Short % of Float (Jun 28, 2019) 45.19%
Short % of Shares Outstanding (Jun 28, 2019) 43.60%
Shares Short (prior month May 31, 2019) 444.42k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 218/1
Last Split Date 3Apr 4, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-41.64%
Return on Equity (ttm)-74.70%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.11M
Net Income Avi to Common (ttm)-6.86M
Diluted EPS (ttm)-8.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.01M
Total Cash Per Share (mrq)7.29
Total Debt (mrq)60k
Total Debt/Equity (mrq)0.82
Current Ratio (mrq)6.61
Book Value Per Share (mrq)6.66

Cash Flow Statement

Operating Cash Flow (ttm)-6.74M
Levered Free Cash Flow (ttm)-4.57M